Shareholders Equity: The sum of preferred and common equity items.
AXM Pharma Inc. (AXMP) had Shareholders Equity of $-0.03M for the most recently reported fiscal year, ending 2017-12-31.
| Income Statement Financials | |
-- |
|
$-0.01M |
|
-- |
|
-- |
|
$0.01M |
|
$-0.01M |
|
$-0.00M |
|
$-0.01M |
|
$-0.01M |
|
$-0.01M |
|
$-0.01M |
|
$-0.01M |
|
$-0.01M |
|
$-0.01M |
|
$-0.01M |
|
158.60M |
|
158.60M |
|
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
$0.00M |
|
$0.03M |
|
-- |
|
-- |
|
$0.03M |
|
$-0.03M |
|
$-0.03M |
|
|
Shareholders Equity |
$-0.03M |
158.60M |
|
| Cash Flow Statement Financials | |
$0.00M |
|
-- |
|
$0.01M |
|
-- |
|
-- |
|
$0.01M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-0.83 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$0.00M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
26.26% |
|
28.94% |
|
-- |
|
28.94% |
|
$-0.00 |
|
$0.00 |
|
$0.00 |
|